Clinical updates in adult immune thrombocytopenia
Top Cited Papers
Open Access
- 25 May 2017
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 129 (21), 2829-2835
- https://doi.org/10.1182/blood-2017-03-754119
Abstract
Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable bleeding symptoms and thrombocytopenia. In the last decade, changes in our understanding of the pathophysiology of the disorder have led to the publication of new guidelines for the diagnosis and management of ITP and standards for terminology. Current evidence supports alternatives to splenectomy for second-line management of patients with persistently low platelet counts and bleeding. Long-term follow-up data suggest both efficacy and safety, in particular, for the thrombopoietin receptor agonists and the occurrence of late remissions. Follow-up of patients who have undergone splenectomy for ITP reveals significant potential risks that should be discussed with patients and may influence clinician and patient choice of second-line therapy. Novel therapeutics are in development to address ongoing treatment gaps.Keywords
This publication has 104 references indexed in Scilit:
- Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpuraVox Sanguinis, 2013
- How I treat thrombocytopenia in pregnancyBlood, 2013
- Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in miceBlood, 2012
- Immune thrombocytopenia in children and adults: what's the same, what's different?Haematologica, 2011
- The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopeniaHaematologica, 2011
- Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research DatabaseHaematologica, 2010
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodiesHaematologica, 2008
- Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodiesHaematologica, 2008
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003